Overview

A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety, tolerability, and efficacy of memantine compared to placebo in outpatients diagnosed with moderate-to-severe dementia of the Alzheimer's type on a concurrent acetylcholinesterase inhibitor (AChEI).
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Memantine